CDK6 and prostate neoplasm: However, Chen et al. [25] found higher CDK6 expression in prostate tumors compared to normal tissues and demonstrated that three CDK6 inhibitors (apigenin, chrysin, and fisetin) could reduce CDK6 expression and inhibit cell proliferation.